Navigation Links
ClearTrial to Provide Guidelines for Accurately Forecasting and Budgeting Adaptive Clinical Trials at CBI Conference

ClearTrial will examine solutions to the budgeting, forecasting, and operational planning challenges presented by adaptive studies. These challenges include creating multiple and varied trial scenarios accounting for shifting resource allocations, timelines, treatment arms, and more.

Chicago (PRWEB) January 15, 2009 -- ClearTrial (, a leading provider of clinical trial software for clinical trial operations planning, budgeting, and outsourcing, announced today that Deirdre BeVard, ClearTrial Vice President of Clinical Services, will speak at the CBI Forecasting & Budgeting conference at the Crowne Plaza Hotel in Philadelphia, February 3-4, 2009. BeVard will address the rapidly growing use of adaptive trial design in clinical development, focusing on helping life sciences companies address the unique challenges this approach poses for accurate forecasting, budgeting, and operational planning.

While promising significant benefits such as better safety and efficacy data and faster drug development with lower costs, adaptive clinical trials place a far greater burden on planning and initial trial design. Adaptive trials are challenging to forecast and budget since planners must create multiple and varied trial scenarios accounting for shifting resource allocations, timelines, treatment arms, and more. In addition, adaptive trials place a greater burden than traditional trials on certain areas such as biostatistics, data management, and project management.

Attendees of this session will discover:

-Common design principles of adaptive trials and their operational impact
-Practical guidelines for accurately forecasting and budgeting adaptive trials
-The importance of activity-based planning to successful adaptive trial forecasting and budgeting
-Critical operational success factors for initial adaptive trial design

BeVard offers 20 years of industry experience to conference attendees, with an extensive background in clinical trial planning. Prior to joining ClearTrial, she was Executive Director, Clinical Research for the Physician Alliance for Clinical Research (PACR), formerly part of HealthSouth. BeVard also served as Senior Director of Clinical Operations at Otsuka Maryland Research Institute, where she was responsible for the direction, strategy and execution of global clinical trial operations.

About ClearTrial®
ClearTrial® is a leading provider of clinical trial software for clinical operations planning, budgeting, and outsourcing. ClearTrial software helps pharmaceutical, biotechnology, medical device companies, and CROs expedite the clinical development process without sacrificing quality of results. The company's software products support clinical operations, resource planning, and outsourcing departments with a single solution that promotes speed and consistency, while maintaining flexibility to handle different study requirements. For more information please visit

ClearTrial® and the ClearTrial logo are registered trademarks owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners.


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study provides hope that some transplant patients could live free of antirejection drugs
2. Study provides hope that some transplant patients could live free of anti-rejection drugs
3. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
4. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
5. USAID Provides Additional Wildfire Assistance to Greece
6. MinuteClinic Becomes Participating Provider with Assurant Health
7. Over 500,000 Health Care Providers Now Cutting Costs, Saving Time Through CAQH Administrative Simplification Initiative
8. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
9. New knock-out gene model provides molecular clues to breast cancer
10. Area Health Care Providers Announce Plans to Integrate Services
11. Crdentia Selected by High Rock Raceway to Provide Healthcare Staffing Services
Post Your Comments:
(Date:11/26/2015)... ... ... The Catalent Applied Drug Delivery Institute today announced a ... selection in early phase drug development. The first of these is to be ... UK’s emerging life sciences companies, corporate partners, and investors, at Milton Park, Oxford, ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... health and wellness consultation, has collaborated with Women’s Web – an online ... queries on topics on mental and emotional well-being relationship, life balance, stress, ...
(Date:11/25/2015)... ... November 25, 2015 , ... Finnleo, a leader in the traditional and ... of traditional and far-infrared saunas. , For traditional saunas, Finnleo is offering ... Finnish sauna wood, and Finnleo uses only European Grade A Nordic White Spruce from ...
(Date:11/25/2015)... Rouge, LA (PRWEB) , ... November 25, 2015 , ... ... in the United States District Court of Connecticut on behalf of a home health ... behalf of all current or former home health care workers employed by Humana, Inc., ...
(Date:11/25/2015)... ... , ... On November 25, 2015, officials of Narconon Arrowhead , the ... of a new cutting edge recovery program that has been 50 years in the ... alcohol-addicted individuals with the purpose to free addicts from the symptoms and negative behaviors ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ... "Radioimmunoassay Market by Type (Reagents & ... Academics, Clinical Diagnostic Labs), Application (Research, Clinical ... 2020" report to their offering. ... addition of the "Radioimmunoassay Market by ...
(Date:11/25/2015)... ) ... "Global Brain Monitoring Devices Market 2015-2019" ... ) has announced the addition of ... 2015-2019" report to their offering. ... ) has announced the addition of the ...
(Date:11/25/2015)... Calif. , Nov. 25, 2015  Amgen (NASDAQ: ... Biologics License Application (BLA) with the United ... for ABP 501, a biosimilar candidate to Humira ® ... adalimumab biosimilar application submitted to the FDA and represents ... Sean E. Harper , M.D., executive vice ...
Breaking Medicine Technology: